Trends in Drug Discovery in Diabetes and Obesity
Trends in Drug Discovery in Diabetes and Obesity
Trends and challenges in one of the key areas of contemporary drug development - presented by industry professionals from leading pharmaceutical companies.
Tabel of contents
Tabel of contents
Preface
Chapter 1. The role of gut peptides in the regulation of body weight.
Chapter 2. Agonists and antagonists of the human GIP receptor
Chapter 3. Amylin ? biological aspects
Chapter 4. Peptide-based GLP-1 receptor agonists for the treatment of type 2 diabetes and obesity
Chapter 5. Oral agents used to treat type 2 diabetes and obesity
Chapter 6. Trends in the field of insulin drug design
Chapter 7. Neuropeptide Y receptor ligands and opportunities within diabetes and obesity
Chapter 8 PrRP-GPR10 signalling and metabolism
Chapter 9. The becoming of dasiglucagon
Linderoth, Lars
Ostergaard, Soren
Fischer, János
Klein, Christian
Childers, Wayne E.
Rotella, David P.
| ISBN | 9783527353309 |
|---|---|
| Media type | Book |
| Edition number | 1. Auflage |
| Copyright year | 2026 |
| Publisher | Wiley-VCH |
| Illustrations | 50 SW-Abb., 100 Farbabb. |
| Language | English |
